717% Since May 2019?!
Members had the chance to more than 10X their TOTAL PORTFOLIOS by following our recommendations since May 2019...

That's why for one week you can join us as we analyze the market LIVE...

And get all our market intelligence and real-time trading recommendations...

Just RSVP Here (No Cost, No Obligation).
Learn more.
pixel

LCT Insider Trading (Living Cell Technologies)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Living Cell Technologies Insider Trading History Chart

This chart shows the insider buying and selling history at Living Cell Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Living Cell Technologies Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for LCT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
717% Since May 2019?!
Members had the chance to more than 10X their TOTAL PORTFOLIOS by following our recommendations since May 2019...

That's why for one week you can join us as we analyze the market LIVE...

And get all our market intelligence and real-time trading recommendations...

Just RSVP Here (No Cost, No Obligation).
Learn more.
pixel

Living Cell Technologies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/1/2021Kenneth (Ken) TaylorInsiderExpiry350,000A$0.01A$4,550.00
12/6/2019Carolyn SueInsiderIssued600,000A$0.02A$10,200.00
12/13/2018Robert ElliottInsiderIssued600,000A$0.04A$24,000.00
11/6/2018Robert ElliottInsiderBuy210,000A$0.05A$9,660.00
See Full Table
Insider Selling at Living Cell Technologies?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Living Cell Technologies and related companies.

SEC Filings (Institutional Ownership Changes) for Living Cell Technologies (ASX:LCT)

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. The company's lead product is NTCELL, an alginate coated capsule, which is in clinical trials for the treatment of Parkinson's disease. It also develops LP-003, a peptide drug that reduces caloric intake targeting obesity; and LC-002, a novel calcitonin gene-related peptide antagonist targeting migraine. Living Cell Technologies Limited has a research collaboration agreement with the University of Auckland to identify products that utilize patented novel peptide synthetic chemistry technology for the treatments for obesity and migraine. The company was founded in 1987 and is based in Melbourne, Australia.
Read More on Living Cell Technologies

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

76,622 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Living Cell Technologies?

Living Cell Technologies' top insider shareholders include:
  1. Carolyn Sue (Insider)
  2. Kenneth (Ken) Taylor (Insider)
717% Since May 2019?!
Members had the chance to more than 10X their TOTAL PORTFOLIOS by following our recommendations since May 2019...

That's why for one week you can join us as we analyze the market LIVE...

And get all our market intelligence and real-time trading recommendations...

Just RSVP Here (No Cost, No Obligation).
Learn more.
pixel